Home
TELA
TELA News

Latest TELA Bio Inc. (TELA) News on August 17, 2025

GuruFocus.com

2 months ago

Aroa Biosurgery Ltd (AROAF) (FY25) Earnings Call Highlights: Surpassing Revenue Expectations ...

TELA Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

2 months ago

TELA Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

MT Newswires

2 months ago

TELA Bio Launches Tissue Matrix in Europe for Inguinal Hernia Repair

TELA Bio Announces European Commercial Launch of OviTex® Inguinal for Robotic and Laparoscopic Inguinal Hernia Repair

GlobeNewswire

2 months ago

TELA Bio Announces European Commercial Launch of OviTex® Inguinal for Robotic and Laparoscopic Inguinal Hernia Repair

TELA Bio Appoints Jeffrey Blizard as President

GlobeNewswire

2 months ago

TELA Bio Appoints Jeffrey Blizard as President

TELA Bio to Participate in the 2025 Jefferies Global Healthcare Conference

GlobeNewswire

3 months ago

TELA Bio to Participate in the 2025 Jefferies Global Healthcare Conference

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

3 months ago

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

TELA Bio Inc (TELA) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amid Challenges

GuruFocus.com

3 months ago

TELA Bio Inc (TELA) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amid Challenges

TELA Bio, Inc. (TELA) Reports Q1 Loss, Tops Revenue Estimates

Zacks

3 months ago

TELA Bio, Inc. (TELA) Reports Q1 Loss, Tops Revenue Estimates

TELA Bio Reports First Quarter 2025 Financial Results

GlobeNewswire

3 months ago

TELA Bio Reports First Quarter 2025 Financial Results

TELA Bio Inc (TELA) Q1 2025 Earnings Report Preview: What to Expect

GuruFocus.com

3 months ago

TELA Bio Inc (TELA) Q1 2025 Earnings Report Preview: What to Expect

Favourable Signals For TELA Bio: Numerous Insiders Acquired Stock

Simply Wall St.

4 months ago

Favourable Signals For TELA Bio: Numerous Insiders Acquired Stock

TELA Bio Inc (TELA) Q4 2024 Earnings Call Highlights: Navigating Growth and Challenges with ...

GuruFocus.com

4 months ago

TELA Bio Inc (TELA) Q4 2024 Earnings Call Highlights: Navigating Growth and Challenges with ...

TELA Bio to Announce First Quarter 2025 Financial Results

GlobeNewswire

4 months ago

TELA Bio to Announce First Quarter 2025 Financial Results

TELA Bio Announces U.S. Commercial Launch of Larger Sizes of OviTex® PRS for Plastic and Reconstructive Surgery

GlobeNewswire

5 months ago

TELA Bio Announces U.S. Commercial Launch of Larger Sizes of OviTex® PRS for Plastic and Reconstructive Surgery

TELA Bio Full Year 2024 Earnings: Revenues Disappoint

Simply Wall St.

5 months ago

TELA Bio Full Year 2024 Earnings: Revenues Disappoint

MT Newswires

5 months ago

Sector Update: Health Care

TELA Bio Shares Drop 43% After Weak Q4 Growth, High Sales Turnover

GuruFocus.com

5 months ago

TELA Bio Shares Drop 43% After Weak Q4 Growth, High Sales Turnover

Earnings To Watch: TELA Bio Inc (TELA) Reports Q4 2024 Result

GuruFocus.com

5 months ago

Earnings To Watch: TELA Bio Inc (TELA) Reports Q4 2024 Result

MT Newswires

5 months ago

Top Premarket Decliners

MT Newswires

5 months ago

Piper Sandler Downgrades TELA Bio to Neutral From Overweight, Adjusts Price Target to $2 From $5

TELA Bio, Inc. (TELA) Reports Q4 Loss, Misses Revenue Estimates

Zacks

5 months ago

TELA Bio, Inc. (TELA) Reports Q4 Loss, Misses Revenue Estimates

MT Newswires

5 months ago

TELA Bio Q4 Net Loss Narrows, Revenue Rises; 2025 Sales Outlook Set -- Shares Fall After Hours

TELA Bio Reports Fourth Quarter and Full Year 2024 Financial Results

GlobeNewswire

5 months ago

TELA Bio Reports Fourth Quarter and Full Year 2024 Financial Results

TELA Bio to Announce Fourth Quarter and Full Year 2024 Financial Results

GlobeNewswire

6 months ago

TELA Bio to Announce Fourth Quarter and Full Year 2024 Financial Results

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

6 months ago

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

7 months ago

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Retail investors account for 41% of TELA Bio, Inc.'s (NASDAQ:TELA) ownership, while institutions account for 28%

Simply Wall St.

7 months ago

Retail investors account for 41% of TELA Bio, Inc.'s (NASDAQ:TELA) ownership, while institutions account for 28%

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

8 months ago

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

The past five years for TELA Bio (NASDAQ:TELA) investors has not been profitable

Simply Wall St.

9 months ago

The past five years for TELA Bio (NASDAQ:TELA) investors has not been profitable

TELA Bio to Participate in Piper Sandler’s 36th Annual Healthcare Conference

GlobeNewswire

9 months ago

TELA Bio to Participate in Piper Sandler’s 36th Annual Healthcare Conference

TELA Bio Third Quarter 2024 Earnings: EPS Beats Expectations

Simply Wall St.

9 months ago

TELA Bio Third Quarter 2024 Earnings: EPS Beats Expectations

Thomson Reuters StreetEvents

9 months ago

Q3 2024 TELA Bio Inc Earnings Call

TELA Bio Inc (TELA) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ...

GuruFocus.com

9 months ago

TELA Bio Inc (TELA) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ...

TELA Bio, Inc. (TELA) Reports Q3 Loss, Lags Revenue Estimates

Zacks

9 months ago

TELA Bio, Inc. (TELA) Reports Q3 Loss, Lags Revenue Estimates

TELA Bio Reports Third Quarter 2024 Financial Results

GlobeNewswire

9 months ago

TELA Bio Reports Third Quarter 2024 Financial Results

What To Expect From TELA Bio Inc (TELA) Q3 2024 Earnings

GuruFocus.com

9 months ago

What To Expect From TELA Bio Inc (TELA) Q3 2024 Earnings

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

10 months ago

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

US Penny Stocks To Watch In October 2024

Simply Wall St.

10 months ago

US Penny Stocks To Watch In October 2024

Antony Koblish Bought 42% More Shares In TELA Bio

Simply Wall St.

10 months ago

Antony Koblish Bought 42% More Shares In TELA Bio

OrbiMed Advisors LLC Reduces Stake in TELA Bio Inc

GuruFocus.com

10 months ago

OrbiMed Advisors LLC Reduces Stake in TELA Bio Inc

TELA Bio Announces Closing of Public Offering of Common Stock and Pre-Funded Warrants and Full Exercise of the Underwriters’ Option to Purchase Additional Shares

GlobeNewswire

10 months ago

TELA Bio Announces Closing of Public Offering of Common Stock and Pre-Funded Warrants and Full Exercise of the Underwriters’ Option to Purchase Additional Shares

TELA Bio Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants

GlobeNewswire

10 months ago

TELA Bio Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants

TELA Bio Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

GlobeNewswire

10 months ago

TELA Bio Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

TELA Bio to Announce Third Quarter 2024 Financial Results

GlobeNewswire

10 months ago

TELA Bio to Announce Third Quarter 2024 Financial Results

Orbimed Advisors LLC Reduces Stake in TELA Bio Inc

GuruFocus.com

a year ago

Orbimed Advisors LLC Reduces Stake in TELA Bio Inc

Zai Lab Limited (ZLAB) Surges 11.1%: Is This an Indication of Further Gains?

Zacks

a year ago

Zai Lab Limited (ZLAB) Surges 11.1%: Is This an Indication of Further Gains?

TELA Bio Second Quarter 2024 Earnings: Misses Expectations

Simply Wall St.

a year ago

TELA Bio Second Quarter 2024 Earnings: Misses Expectations

TELA Bio, Inc. (TELA) Reports Q2 Loss, Lags Revenue Estimates

Zacks

a year ago

TELA Bio, Inc. (TELA) Reports Q2 Loss, Lags Revenue Estimates

TELA Bio Reports Second Quarter 2024 Financial Results and Reiterates Full Year 2024 Revenue Guidance

GlobeNewswire

a year ago

TELA Bio Reports Second Quarter 2024 Financial Results and Reiterates Full Year 2024 Revenue Guidance

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

a year ago

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Artivion (AORT) Surpasses Q2 Earnings and Revenue Estimates

Zacks

a year ago

Artivion (AORT) Surpasses Q2 Earnings and Revenue Estimates

TELA Bio, Inc. (NASDAQ:TELA) has caught the attention of institutional investors who hold a sizeable 42% stake

Simply Wall St.

a year ago

TELA Bio, Inc. (NASDAQ:TELA) has caught the attention of institutional investors who hold a sizeable 42% stake

TELA Bio to Participate in the Canaccord Genuity 44th Annual Growth Conference

GlobeNewswire

a year ago

TELA Bio to Participate in the Canaccord Genuity 44th Annual Growth Conference

TELA Bio to Announce Second Quarter 2024 Financial Results

GlobeNewswire

a year ago

TELA Bio to Announce Second Quarter 2024 Financial Results

Spirit Airlines not considering Chapter 11 bankruptcy, CNBC reports

Reuters

a year ago

Spirit Airlines not considering Chapter 11 bankruptcy, CNBC reports

DaBaby and Stunna 4 Vegas's "NO DRIBBLE" Joins Music Licensing, Inc.'s Portfolio

Newsfile

a year ago

DaBaby and Stunna 4 Vegas's "NO DRIBBLE" Joins Music Licensing, Inc.'s Portfolio

BW Energy: Mandatory notifications of trade by primary insiders and close associates

GlobeNewswire

a year ago

BW Energy: Mandatory notifications of trade by primary insiders and close associates

Aqua-Tots Swim School Splashes Into Summer With Highly-Anticipated Grand Opening in Henderson, Nevada

GlobeNewswire

a year ago

Aqua-Tots Swim School Splashes Into Summer With Highly-Anticipated Grand Opening in Henderson, Nevada

Sage Potash Grants Stock Options

CNW Group

a year ago

Sage Potash Grants Stock Options

Moderna Files FDA Application for the JN.1 Targeting COVID-19 Vaccine

ACCESSWIRE

a year ago

Moderna Files FDA Application for the JN.1 Targeting COVID-19 Vaccine

AllianceBernstein: Office Space: Looking Past the Doom and Gloom

ACCESSWIRE

a year ago

AllianceBernstein: Office Space: Looking Past the Doom and Gloom

Decisions of the Ordinary General Shareholders' Meeting of Novaturas AB

GlobeNewswire

a year ago

Decisions of the Ordinary General Shareholders' Meeting of Novaturas AB

TELA Bio Appoints Jeffrey Blizard to its Board of Directors

GlobeNewswire

a year ago

TELA Bio Appoints Jeffrey Blizard to its Board of Directors

TELA Bio Appoints Greg Firestone as Chief Commercial Officer

GlobeNewswire

a year ago

TELA Bio Appoints Greg Firestone as Chief Commercial Officer

TELA Bio, Inc. (NASDAQ:TELA) Q1 2024 Earnings Call Transcript

Insider Monkey

a year ago

TELA Bio, Inc. (NASDAQ:TELA) Q1 2024 Earnings Call Transcript

TELA Bio First Quarter 2024 Earnings: US$0.23 loss per share (vs US$0.63 loss in 1Q 2023)

Simply Wall St.

a year ago

TELA Bio First Quarter 2024 Earnings: US$0.23 loss per share (vs US$0.63 loss in 1Q 2023)

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

a year ago

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GuruFocus.com

a year ago

TELA Bio Inc (TELA) Reports Q1 2024 Earnings: Revenue Surpasses Estimates Amidst Continued Growth

MT Newswires

a year ago

Piper Sandler Adjusts Price Target on TELA Bio to $10 From $12, Maintains Overweight Rating

TELA Bio Reports First Quarter 2024 Financial Results

GlobeNewswire

a year ago

TELA Bio Reports First Quarter 2024 Financial Results

TELA Bio to Announce First Quarter 2024 Financial Results

GlobeNewswire

a year ago

TELA Bio to Announce First Quarter 2024 Financial Results

TELA Bio Announces U.S. Commercial Launch of Robotic-Compatible OviTex® IHR – Addressing the Need for a More Natural Repair in Inguinal Hernia Procedures

GlobeNewswire

a year ago

TELA Bio Announces U.S. Commercial Launch of Robotic-Compatible OviTex® IHR – Addressing the Need for a More Natural Repair in Inguinal Hernia Procedures

Syros Pharmaceuticals (SYRS) Soars 22.2%: Is Further Upside Left in the Stock?

Zacks

a year ago

Syros Pharmaceuticals (SYRS) Soars 22.2%: Is Further Upside Left in the Stock?

TELA Bio Welcomes Acclaimed Surgeon as Vice President of Medical Affairs and Surgeon Strategy

GlobeNewswire

a year ago

TELA Bio Welcomes Acclaimed Surgeon as Vice President of Medical Affairs and Surgeon Strategy

Analysts Are Updating Their TELA Bio, Inc. (NASDAQ:TELA) Estimates After Its Full-Year Results

Simply Wall St.

a year ago

Analysts Are Updating Their TELA Bio, Inc. (NASDAQ:TELA) Estimates After Its Full-Year Results

TELA Bio Full Year 2023 Earnings: US$2.04 loss per share (vs US$2.72 loss in FY 2022)

Simply Wall St.

a year ago

TELA Bio Full Year 2023 Earnings: US$2.04 loss per share (vs US$2.72 loss in FY 2022)

TELA Bio, Inc. (NASDAQ:TELA) Q4 2023 Earnings Call Transcript

Insider Monkey

a year ago

TELA Bio, Inc. (NASDAQ:TELA) Q4 2023 Earnings Call Transcript

Thomson Reuters StreetEvents

a year ago

Q4 2023 TELA Bio Inc Earnings Call

TELA Bio Inc Reports Robust Revenue Growth in Q4 and Full Year 2023

GuruFocus.com

a year ago

TELA Bio Inc Reports Robust Revenue Growth in Q4 and Full Year 2023

TELA Bio, Inc. (TELA) Reports Q4 Loss, Tops Revenue Estimates

Zacks

a year ago

TELA Bio, Inc. (TELA) Reports Q4 Loss, Tops Revenue Estimates

TELA Bio Achieves Record Fourth Quarter and Full Year 2023 Revenues and Reports Complete Financial Results

GlobeNewswire

a year ago

TELA Bio Achieves Record Fourth Quarter and Full Year 2023 Revenues and Reports Complete Financial Results

TELA Bio Announces U.S. Commercial Launch of LIQUIFIX™ – the Only FDA-Approved Liquid Adhesive for Internal Use in Hernia Surgery

GlobeNewswire

a year ago

TELA Bio Announces U.S. Commercial Launch of LIQUIFIX™ – the Only FDA-Approved Liquid Adhesive for Internal Use in Hernia Surgery

MIMEDX Expands Portfolio with Fibrillar Collagen Wound Dressing

GlobeNewswire

a year ago

MIMEDX Expands Portfolio with Fibrillar Collagen Wound Dressing

TELA Bio Announces Sale of Distribution Rights for Wound Care Product to MIMEDX

GlobeNewswire

a year ago

TELA Bio Announces Sale of Distribution Rights for Wound Care Product to MIMEDX

TELA Bio to Announce Fourth Quarter and Full Year 2023 Financial Results

GlobeNewswire

a year ago

TELA Bio to Announce Fourth Quarter and Full Year 2023 Financial Results

Wave Life Sciences (WVE) Surges 10.9%: Is This an Indication of Further Gains?

Zacks

a year ago

Wave Life Sciences (WVE) Surges 10.9%: Is This an Indication of Further Gains?

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

a year ago

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

With 54% institutional ownership, TELA Bio, Inc. (NASDAQ:TELA) is a favorite amongst the big guns

Simply Wall St.

2 years ago

With 54% institutional ownership, TELA Bio, Inc. (NASDAQ:TELA) is a favorite amongst the big guns

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

2 years ago

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

TScan Therapeutics Announces Best Abstracts Award and Upcoming Oral Presentation at the 2024 Tandem Meetings of ASTCT and CIBMTR

GlobeNewswire

2 years ago

TScan Therapeutics Announces Best Abstracts Award and Upcoming Oral Presentation at the 2024 Tandem Meetings of ASTCT and CIBMTR

3 Pot Stocks to Avoid Like the Plague in 2024

Motley Fool

2 years ago

3 Pot Stocks to Avoid Like the Plague in 2024

GuruFocus.com

2 years ago

NVE Corp (NVEC) Reports Decrease in Q3 Revenue and Net Income, Maintains Dividend

Associated Press Finance

2 years ago

NVE: Fiscal Q3 Earnings Snapshot

NVE Corporation Reports Third Quarter Results and Announces Quarterly Dividend

GlobeNewswire

2 years ago

NVE Corporation Reports Third Quarter Results and Announces Quarterly Dividend

TELA Bio to Take Part in Connecting the Dots

GlobeNewswire

2 years ago

TELA Bio to Take Part in Connecting the Dots

7 ‘Turkey’ Stocks to Pluck from Your Portfolio BEFORE Thanksgiving

InvestorPlace

2 years ago

7 ‘Turkey’ Stocks to Pluck from Your Portfolio BEFORE Thanksgiving

TELA Bio to Participate in Piper Sandler’s 35th Annual Healthcare Conference

GlobeNewswire

2 years ago

TELA Bio to Participate in Piper Sandler’s 35th Annual Healthcare Conference

TELA Bio, Inc. (NASDAQ:TELA) Q3 2023 Earnings Call Transcript

Insider Monkey

2 years ago

TELA Bio, Inc. (NASDAQ:TELA) Q3 2023 Earnings Call Transcript

TELA Bio Reports Third Quarter 2023 Financial Results

GlobeNewswire

2 years ago

TELA Bio Reports Third Quarter 2023 Financial Results

Share on Social Networks: